Prevalence of metabolic syndrome in COPD patients and its consequences. - Wikidata - awgldk - TriplyDB

Prevalence of metabolic syndrome in COPD patients and its consequences.

Prevalence of metabolic syndrome in COPD patients and its consequences.

http://www.wikidata.org/entity/Q33783840

about

Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management Metabolic Syndrome and the Lung Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation Impact of overlap syndrome on severity of acute exacerbation of chronic obstructive pulmonary disease Comparison of frequency of insulin resistance in patients with chronic obstructive pulmonary disease with normal controls.The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease.Relationship Between Forced Vital Capacity and Framingham Cardiovascular Risk Score Beyond the Presence of Metabolic Syndrome: The Fourth Korea National Health and Nutrition Examination Survey Relationship between metabolic syndrome and epicardial fat tissue thickness in patients with chronic obstructive pulmonary disease.Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review.Chronic obstructive pulmonary disease candidate gene prioritization based on metabolic networks and functional information.Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D.Prioritizing chronic obstructive pulmonary disease (COPD) candidate genes in COPD-related networks.Chronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study.Obesity and Metabolic Abnormalities in Chronic Obstructive Pulmonary Disease.Obesity and metabolic syndrome in COPD: is exercise the answer?Relationship between airway obstruction and incidence of metabolic syndrome in Korea: a community-based cohort study.Ectopic adiposity and cardiometabolic health in COPD

P2860

Q26799659-256B7127-7817-47F4-9EB9-0807C9630B6D Q28384152-BCA83FD1-A907-4236-8D2A-0D9669470320 Q28397350-F2F819D2-B060-4163-8B04-5FCC26EED9CD Q33554524-6C815464-7245-464B-9A71-FF713F6F0C7E Q36330721-DFEA0EAD-BEEE-4EB2-86B2-0086070FB050 Q36552979-0CE4869E-8481-4CF6-81D5-0F2CE1C5E251 Q37006598-04696055-5BBC-4338-B290-548CC61268E9 Q37006609-9D21DD4D-40A4-40E3-A2C3-5A5B87A36273 Q37328619-A8C13875-1510-4014-AD7A-0CD21AC1F30A Q37672908-E7F84B10-6E3A-4A95-8A9F-0EF969974DC5 Q38710985-1163147C-EC71-47CE-B689-266A4FC35AD6 Q38749690-9DD6A686-A7C4-4804-8FCD-95FC070FCD30 Q41616141-85A3E5B7-C471-4347-BB20-45EF7F18FB70 Q45793325-C7C25554-1E13-4D8D-90ED-5A8A3B623274 Q47113578-B74DC2BB-B991-48BB-A217-17A1CA671836 Q47146553-CD9D9730-3151-4F52-874D-5156FB5C2268 Q47704314-4D0D267B-3CDD-43CE-8D7D-FAE457C7C164 Q47850975-4E10602F-733A-4586-A57B-F162CA3BC9DD Q55463812-0667D53D-62FA-4551-8E18-741E91C2AB0E Q58563190-017F83FC-217B-47F6-9D46-E580504BDFB9

P2860

Prevalence of metabolic syndrome in COPD patients and its consequences.

http://www.wikidata.org/entity/Q33783840

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prevalence of metabolic syndrome in COPD patients and its consequences.

@ast

Prevalence of metabolic syndrome in COPD patients and its consequences.

@en

type

label

Prevalence of metabolic syndrome in COPD patients and its consequences.

@ast

Prevalence of metabolic syndrome in COPD patients and its consequences.

@en

prefLabel

Prevalence of metabolic syndrome in COPD patients and its consequences.

@ast

Prevalence of metabolic syndrome in COPD patients and its consequences.

@en

P1433

Q33783840-22B41A85-67D3-4442-AD2E-39F05F1C0B50

P1476

Q33783840-C16AB393-B168-479C-8919-AF41DEDE4205

P2093

Q33783840-08BF2A17-5038-4487-8568-7D1E3A7D5E28

Q33783840-27408EB8-9798-48CC-89BB-0056460D851F

Q33783840-37673854-9CD1-4B7F-B1EB-F409579CD1EE

Q33783840-90C3016F-4274-42B5-903F-FE2C6755AB13

Q33783840-928BFEED-7F57-4335-AE99-C09EE8D4DD93

Q33783840-FF7DE14F-24F2-4141-91CA-72E1D10C9CD8

P2860

Q33783840-0215FC7F-6C3A-4705-A9E2-F88A722BE3E7

Q33783840-0A050EDB-F182-46EE-8DA5-113CE9BB7528

Q33783840-1BB7845C-26B1-4910-B9CB-481FDDC88D65

Q33783840-27DC404B-6B3E-4B96-B244-C166E3D50902

Q33783840-31ABC36A-F913-4F2F-9617-32A2035C43AD

Q33783840-3482EEDA-8DE1-4A5B-B210-D208F6DCC46D

Q33783840-34C55EC5-B608-4216-991A-CB669916BD44

Q33783840-3998AFFD-DDC4-49AF-8627-EB1F21D211A1

Q33783840-5684B343-A742-48B8-B5D5-69C48C745760

Q33783840-60A1ED17-8BA4-4C51-B5A2-9BC09F356CFF

P304

Q33783840-207DF1B6-2CD3-4E0E-994E-D3E9E75FEC4E

P31

Q33783840-DBC2D13F-B39D-4829-B14E-E668EA461497

P356

Q33783840-B10AE160-B540-43F0-9F42-D2ECD59B336F

P407

Q33783840-8A931013-C2CE-41BF-AF68-56419F6B8130

P433

Q33783840-B0AB8FE2-A202-4D60-AB79-BBAB17F16192

P478

Q33783840-6CB59744-394C-422B-94F2-B3C718DC28B8

P50

Q33783840-045887E1-24B1-49AB-A382-F39FFD5F7114

Q33783840-AB08722B-342E-4ADB-B0D8-13DDE600D4E4

Q33783840-DE01F4A6-293A-4B04-AA4F-A4187C6C5EDA

P577

Q33783840-C1B994A3-CFCC-4729-873C-2E8FE407DE40

P5875

Q33783840-085AC3E5-83F5-4748-83FC-3CD32748F320

P698

Q33783840-16DE4F68-3538-4371-89BB-16211F50AA9B

P921

Q33783840-CBF561A1-8A0F-42CF-9C90-F58062941D84

Q33783840-DA88444D-6ADF-4448-8CCC-614430A114FA

P932

Q33783840-E0D80C23-0D2F-4D2A-941C-D83126FBC560

P356

JOURNAL.PONE.0098013

P1433

P1476

Prevalence of metabolic syndrome in COPD patients and its consequences.

@en

P2093

Corrine K Hanson

http://www.w3.org/2001/XMLSchema#string

Erica P A Rutten

http://www.w3.org/2001/XMLSchema#string

Lowie E G W Vanfleteren

http://www.w3.org/2001/XMLSchema#string

Marie-Kathrin Breyer

http://www.w3.org/2001/XMLSchema#string

Miriam T J Groenen

http://www.w3.org/2001/XMLSchema#string

Piet L B Bruijnzeel

http://www.w3.org/2001/XMLSchema#string

P2860

The hospital anxiety and depression scale

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

The metabolic syndrome

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease

Body composition and exercise performance in patients with chronic obstructive pulmonary disease.

Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.

Physical activity or fitness and the metabolic syndrome.

Systemic manifestations and comorbidities of COPD.

P304

e98013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0098013

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Martijn A Spruit

Frits M E Franssen

Emiel F M Wouters

P577

2014-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263288894

http://www.w3.org/2001/XMLSchema#string

P698

24950070

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

metabolic syndrome

P932

4064974

http://www.w3.org/2001/XMLSchema#string